Quest Diagnostics Inc Non Peo Neo Avg Total Comp Amt
Quest Diagnostics Inc (DGX) reported Non Peo Neo Avg Total Comp Amt of $3.28 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-06.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-06
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $3.28M DEF 14A · filed 2026-04-06 |
| 2024-12-31 | $3.02M DEF 14A · filed 2026-04-06 |
| 2023-12-31 | $2.85M DEF 14A · filed 2026-04-06 |
| 2022-12-31 | $3.39M DEF 14A · filed 2026-04-06 |
| 2021-12-31 | $3.43M DEF 14A · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |